Home › Forums › Infexion Connexion › Pall Breathing Filters Retain 99.999% of Aerosolized SARS-CoV-2.
- This topic has 0 replies, 1 voice, and was last updated 3 years, 3 months ago by ACIPC Office.
-
AuthorPosts
-
26/08/2021 at 9:39 am #78344
(Paid content)
In response to popular demand, we are pleased to confirm that our CE marked breathing system filters are now validated for SARS-CoV-2*.
As the world continues to battle the SARS pandemic, which has claimed the lives of more than 3 million people and infected more than 150 million, the issue of contamination containment has continued to be a major source of concern. To mitigate these issues, we have upgraded our breathing portfolio to be highly efficient in retaining the SARS-CoV-2.We have subjected representative samples of our Ultipor 25, Ultipor 100, and BB50TE to vigorous testing, challenging each filter with a viral load of > 100 million virus copies. After extensive testing, we can confirm that all filters consistently retained more than 99.999% of the aerosolized virus. The SARS-CoV-2 retention claim has not been cleared by the FDA for the US versions of these filters.
This result is also in alignment with our earlier work, which demonstrated >99.999% retention of other airborne human pathogenic viruses and bacteria. Our Breathing System Filters contain a highly efficient hydrophobic filter medium and also showed 100% retention of liquid-borne human pathogenic viruses like HIV and Hepatitis C.
Rest assured that every filter meets the highest performance standards in the prevention of cross-contamination.
To learn more about our new SARS-CoV-2 Claim, click the link to read our detailed article and request a free sample!
*This Claim has been validated for Europe under CE-mark. It has not been released by the FDA
REQUEST A FREE SAMPLE
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.
The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au
To send a message to the list administrator send an email to admin@acipc.org.au
You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au
-
AuthorPosts
- The forum ‘Infexion Connexion’ is closed to new topics and replies.